NTT DOCOMO BUSINESS and Classiq Enter Strategic Business Partnership to Accelerate Enterprise Adoption of Quantum Computing

 TOKYO - 

Combining Classiq’s quantum software development platform with NTT DOCOMO BUSINESS's real-world implementation expertise to accelerate enterprise quantum adoption

(BUSINESS WIRE) -- NTT DOCOMO BUSINESS, Inc. (formerly NTT Communications Corporation) and Classiq Technologies G.K., the Japanese subsidiary of Classiq Technologies Ltd., today announced a memorandum of understanding establishing a strategic business partnership aimed at accelerating enterprise adoption of quantum computing1 in Japan.

Under the partnership, NTT DOCOMO BUSINESS will propose and sell the Classiq quantum software development platform and work with Classiq to help enterprises identify, develop and validate quantum computing use cases. Classiq will provide the platform, along with expertise and technical support related to quantum algorithms and quantum software technologies. The two companies will combine Classiq’s quantum software technology with NTT DOCOMO BUSINESS’s experience bringing advanced technologies into real-world enterprise environments.

Quantum computing is attracting growing interest across many industries for its potential to address computational challenges in areas including materials development and drug discovery, financial risk analysis, and logistics and network optimization. In Japan, expanding cloud access to gate-based quantum computers2 is enabling more organizations to move beyond research and begin evaluating potential applications.

Developing quantum software, however, requires specialized expertise. Quantum developers must account for concepts such as superposition and entanglement, while quantum circuits3 may also need to be adapted and optimized for different hardware architectures.

The Classiq platform is designed to abstract much of that complexity. It combines agentic AI interfaces, Qmod,4 Classiq’s high-level quantum modeling language, and an automated synthesis engine5 that transforms high-level functional models into optimized quantum circuits. This approach enables developers and technical teams to focus on algorithmic and business requirements while the platform handles many lower-level implementation decisions.

In addition, the Classiq platform supports simulators as well as quantum hardware based on diverse operational principles, including superconducting, neutral-atom, trapped-ion, and photonic architectures. Developers can execute algorithms across multiple types of quantum hardware directly from the Classiq platform without rewriting their code. By allowing organizations to select hardware targets based on their specific application requirements and machine time availability,⁶ the platform enables customers to advance their quantum initiatives and safeguard their digital assets without being locked into any single modality.

“Enterprises are increasingly interested in quantum computing, but turning that interest into concrete use cases requires both accessible development technology and the ability to integrate new capabilities into existing business environments,” said Yuichi Ikejiri, Head of the Innovation Center, NTT DOCOMO BUSINESS. “Through this partnership with Classiq, we will work with customers to identify where quantum computing can create value and help them build the capabilities needed to evaluate and develop practical applications.”

Through joint customer engagements, NTT DOCOMO BUSINESS and Classiq plan to assess business challenges where the Classiq platform can be applied and support the development and execution of quantum algorithms. The companies will work together to develop new use cases, build enterprise quantum readiness and facilitate access to quantum computing resources.

“Japan has a strong base of enterprises already exploring how quantum computing can contribute to their long-term technology strategies,” said Akira Tanaka, VP, Head of APAC at Classiq. “By combining NTT DOCOMO BUSINESS’s enterprise implementation experience with Classiq’s high-level quantum software development technology, we can help more organizations move from learning about quantum computing to developing and evaluating applications around their own business challenges.”

NTT DOCOMO BUSINESS works with customers across industries including manufacturing, financial services, logistics and the public sector, drawing on its experience deploying and operating networks, cloud services and AI infrastructure. The company is also pursuing quantum-related technology validation and implementation initiatives, including the development of a wide-area quantum-secure communications network using quantum key distribution (QKD)7,8 and security technologies leveraging post-quantum cryptography (PQC).9

Going forward, NTT DOCOMO BUSINESS and Classiq aim to expand quantum computing beyond specialized domains and help enterprises develop the capabilities needed to pursue practical business applications.

1

 

Quantum computing is a computing technology that applies principles of quantum mechanics, such as superposition and quantum entanglement, and has the potential to efficiently address problems that are difficult for conventional computers to solve within a practical timeframe.

2

 

Gate-based quantum computing is a general-purpose approach in which basic operations (gates) are applied to qubits in combination to execute a wide range of algorithms. Unlike Ising-machine approaches specialized for combinatorial optimization, gate-based systems are expected to support a broad range of applications, including machine learning and simulation.

3

 

A quantum circuit is an ordered sequence of basic operations (gates) applied to qubits, representing the set of instructions executed by a quantum computer.

4

 

Qmod is a high-level modeling language developed by Classiq for describing quantum algorithms. It enables quantum algorithm concepts to be expressed intuitively and at a high level of abstraction, from which quantum circuits are automatically generated.

5

 

The synthesis engine automatically translates high-level quantum models into quantum circuits while optimizing them against defined constraints and target hardware requirements.

6

 

Machine time refers to the allocated computing time available to execute jobs on a quantum computer.

7

 

Quantum key distribution (QKD) is a technology that uses principles of quantum mechanics to securely share cryptographic keys and can detect attempts by a third party to intercept the key exchange.

8

 

Announced June 30, 2026: “Construction Begins on Japan’s First Wide-Area Quantum-Secure Communications Network Spanning Approximately 600 km Across Tokyo, Nagoya and Osaka.” See https://www.ntt.com/about-us/press-releases/news/article/2026/0630_2.html (in Japanese)

9

 

Post-quantum cryptography (PQC) refers to cryptographic methods designed to provide protection against decryption attacks using quantum computers.

About NTT DOCOMO BUSINESS

NTT DOCOMO BUSINESS, Inc. is Japan’s leading comprehensive global ICT solutions provider. We are an Industrial and Regional AX Platformer driving digital transformation across industries and communities, enabling the development of a decentralized, autonomous, and collaborative society where businesses and communities can thrive sustainably. Our mission is to unlock new value and help create prosperity for all. For more information, please visit https://www.ntt.com/en/.

About Classiq

Classiq, a leading quantum computing software company, provides an enterprise-grade platform that makes it practical to develop scalable, efficient quantum applications. Used by dozens of global enterprises including Rolls Royce, Comcast, The BMW Group, Intesa Sanpaolo, the Classiq platform combines AI agents, Qmod (a high-level quantum programming language) and synthesis-based design automation to accelerate the development of optimized, hardware-ready quantum software. The platform also supports hardware benchmarking, cost and performance optimization, and execution via the cloud across quantum hardware platforms.

Classiq, a Fast Company ‘Next Big Thing in Tech’ award winner, is backed by leading global investors and collaborates with quantum cloud providers, hyperscalers and quantum hardware companies. Follow Classiq on LinkedIn, X or YouTube, visit the Slack community, GitHub repository and www.classiq.io to learn more.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261007985427/en/

Permalink

https://aetoswire.com/en/news/0810202657923

Contacts

Media Contacts

NTT DOCOMO BUSINESS, Inc.

Corporate Planning Department, Public Relations Office

pr-cp@ntt.com

Classiq

Rainier Communications on behalf of Classiq

Michelle Allard McMahon

classiqPR@rainierco.com

Customer Inquiries

NTT DOCOMO BUSINESS, Inc.

Innovation Center

ic-quantum-tech@ntt.com

Sam Altman-Backed Meanwhile Raises $37.5M as Families Across Asia, Europe and the Middle East Turn to Bitcoin Life Insurance

 HAMILTON, Bermuda - Friday, 09. October 2026

Existing investors, led by Bain Capital Crypto, back the first licensed Bitcoin life insurer after its single-premium policy for international clients drives a record year

 

(BUSINESS WIRE)-- Meanwhile, the first life insurer licensed to operate entirely in Bitcoin, today announced $37.5 million in new funding from its existing investors. Bain Capital Crypto led the round, alongside Haun Ventures, Framework Ventures, Pantera Capital, Apollo, Northwestern Mutual Future Ventures, and Morgan Creek Digital. Meanwhile, whose backers also include Sam Altman, has now raised more than $180 million.

The round follows a surge in international demand for Meanwhile’s Bitcoin life insurance policies, particularly in Asia, Europe and the Middle East amid broader macro instability. In early 2026, Meanwhile launched BTC Life 1-Pay, a single-premium whole life policy built for high-net-worth clients outside the United States. It is the company's second product line after BTC 10-Pay, which is purposely designed for US taxpayers. As the company eyes further international growth, Meanwhile has signed 15 brokers serving wealthy families since launch, including in the insurance hubs of Singapore, Hong Kong, the UAE, and Switzerland.

Those broker partners include Lioner, an insurance, trust and family office group with offices in Hong Kong, Singapore and Zurich, and Apeiron Group, a marketplace for high-net-worth life insurance.

"Digital assets are moving into the mainstream of wealth planning, and Lioner is equipped to evolve with them," said Giorgio Jeni, Partner and Head of Switzerland at Lioner, who spent more than 27 years in high-net-worth life insurance and wealth management at HSBC, UBS, Julius Baer and Credit Suisse. "As Bitcoin and other digital assets become part of the wealth landscape, high-net-worth individuals with international interests and ties are thinking more broadly about how they manage wealth for the future. Transparency, sound governance and strong regulation will remain important as new solutions emerge."

"We're reaching a turning point where more high-net-worth clients are asking not just how to hold Bitcoin and digital assets, but how to plan around them and ultimately transfer that wealth to the next generation," said Justin Man, CEO of Apeiron Group. "Life insurance has always been a powerful tool for wealth transfer, but digital assets introduce additional friction around ownership, liquidity and seamless transfer. Meanwhile is the first insurance carrier to pioneer this space and has made a serious investment in serving high-net-worth clients, helping bridge that gap."

BTC Life 1-Pay is life insurance for families who hold some of their wealth in Bitcoin. A client pays one premium in Bitcoin and receives a guaranteed death benefit in Bitcoin for life. The policy's value grows in Bitcoin, and after the first year the owner can borrow up to 90% of it with no repayment schedule and no margin calls. Policies can be owned by individuals, trusts or companies, which makes them a fit for succession and estate planning.

"Wealthy families around the world already hold Bitcoin. What they haven't had is a regulated way to pass it on," said Zac Townsend, co-founder and CEO of Meanwhile. "Brokers came to us because their clients kept asking. This round lets us keep up with them."

The growth shows up in Meanwhile's results. Net long-term underwriting income has already passed last year's total and is on track to more than double in 2026.

"Meanwhile owns every layer of a regulated life insurer and builds it like an AI-enabled startup," said Stefan Cohen, Partner at Bain Capital Crypto. "The growth this year proves the model, and we're glad to back them again."

Meanwhile Insurance Bitcoin (Bermuda) Limited holds the first Class IILT license the BMA has granted, received in July 2024 after two years in the regulator's sandbox. Its balance sheet, reserves and audited financial statements are all denominated in Bitcoin. All policyholder Bitcoin is held with regulated institutional custodians.

How to get in touch

Brokers, private banks and family offices interested in distributing Meanwhile's products can contact Michael Grob at michael.grob@meanwhile.bm.

About Meanwhile

Meanwhile's mission is to enable anyone, anywhere to save, protect and build wealth across generations. Meanwhile Incorporated is the parent company of Meanwhile Insurance Bitcoin (Bermuda) Limited, the first licensed long-term insurer denominated entirely in Bitcoin. Meanwhile was co-founded by Zac Townsend and Max Gasner and is backed by Sam Altman, Bain Capital Crypto, Haun Ventures, Pantera Capital, Apollo, Northwestern Mutual Future Ventures, MS&AD, Framework Ventures, Morgan Creek Digital, Fulgur Ventures and others.

Meanwhile Insurance Bitcoin (Bermuda) Limited is licensed by the Bermuda Monetary Authority to transact long-term business with Sophisticated Persons only. Products are not available in all jurisdictions and are offered only through appropriately licensed intermediaries where permitted. This release is not an offer or solicitation in any jurisdiction.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261008514088/en/

Permalink

https://www.aetoswire.com/en/news/54618492

Contacts

Media contact: Wachsman – eleanor@wachsman.com

Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions

 We think Gartner recognizes Tecnotree's open, governed approach to agentic AI as operators make AI the engine of their revenue operations

 

(BUSINESS WIRE)--Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, today announced that Gartner has positioned it as a Visionary in the first-ever Magic Quadrant for AI-Enabled CSP Marketing and Sales Solutions.

A new category for a new operating model. CSPs are fighting saturated markets, rising acquisition costs, and accelerating churn. They are responding with AI-driven automation across the full revenue cycle, from segmentation and campaigns to lead management, CPQ, and renewals, increasingly executed by autonomous agents. According to us, Gartner creation of this Magic Quadrant confirms the shift has moved from pilot to boardroom priority.

According to Gartner, Visionaries "understands where the market is going or has a vision for changing market rules, but does not yet execute comparatively well or dies so inconsistently.”

One governed AI architecture, from insight to revenue. Tecnotree's position is built on two platforms. Sensa Fabric is its AI engine: a low-code platform with a built-in control layer that governs and audits every AI model an operator runs, with full model choice and full control. Tecnotree Moments is its customer value management platform, turning that intelligence into revenue by personalizing and triggering offers in real time. Its highest-rated capabilities are AI Marketing Campaigns, Agentic Multi-channel Campaigns, and Agentic Micro Segmentation.

Our Strengths:-

Open standards. TM Forum Diamond Badge, 59 certified Open APIs, and 17 GSMA CAMARA APIs, giving operators architectural freedom with no lock-in.

Flexible pricing. A modular, consumption-based commercial model that scales AI investment with realized value.

Closed-loop retention. Sensa Fabric identifies churn risk, and Moments automatically generates tailored offers and rep scripts, acting before the customer leaves.

Built-in trust. Certifai explainability, model audit trails, and AI output verification deliver accurate, traceable decisions.

One architecture across consumer and enterprise revenue. Tecnotree is bringing the same governed agentic model to enterprise sales, with AI agents for pipeline auditing and RFI/RFP response, integrated with real-time OSS/BSS and billing. As domain-specific language models and multiagent systems mature over the next two years, operators will need a control layer to run them at scale. Sensa Fabric is that control layer.

"From our understanding, Gartner creating this Magic Quadrant confirms what our customers already know: AI in marketing and sales is now core revenue infrastructure for operators," said Prianca Ravichander, CMO & CCO of Tecnotree. "The operators who win this decade will own their AI rather than rent it. That means open, governed, and provably effective. Sensa Fabric gives CSPs command of every model they run, our open APIs guarantee their freedom to evolve, and Moments turns that foundation into measurable growth: sharper campaigns, precise segmentation, and retention that acts before a customer churns. We feel being named a Visionary in the inaugural edition tells us we are defining where this market goes."

Gartner Disclaimer

Gartner, Magic Quadrant for CSP AI-Enabled Marketing and Sales Solutions, Pulkit Pandey, Khurram Shahzad, 15 September 2026

Gartner and Magic Quadrant are trademarks of Gartner, Inc., and/or its affiliates.

Gartner does not endorse any company, vendor, product or service depicted in its publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner publications consist of the opinions of Gartner’s business and technology insights organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this publication, including any warranties of merchantability or fitness for a particular purpose.”

About Tecnotree

Tecnotree is a 5G-ready digital BSS player with AI/ML capabilities and multi-cloud extensibility. It leads TM Forum Open API Conformance with 59 certified Open APIs, including 9 real-world open APIs. Its open-source digital BSS stack covers order-to-cash and subscription management for telecom and digital services; Tecnotree Moments delivers Fintech and B2B2X marketplace capabilities across gaming, health, education, OTT, and other ecosystems. Tecnotree is listed on Nasdaq Helsinki as TEM1V.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261009905430/en/

Permalink

https://www.aetoswire.com/en/news/54618970

Contacts

Media Contact

Prianca Ravichander, CMO Tecnotree

Email: marketing@tecnotree.com www.tecnotree.com

Bentley Systems Announces Winners of the 2026 Year in Infrastructure Awards

 SINGAPORE - Thursday, 08. October 2026 AETOSWire  

New cycle of AI-enabled innovation is helping engineers solve harder problems faster

 

(BUSINESS WIRE)--(The Bentley Systems 2026 Year in Infrastructure Event) – Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced the winners of the 2026 Year in Infrastructure Awards. For more than 20 years, the awards have honored the extraordinary work of infrastructure professionals and their innovative use of Bentley software to improve how infrastructure is designed, built, and operated.

In 2026, over 300 projects were nominated by organizations in 53 countries. Winners were selected across 12 categories spanning the infrastructure lifecycle, industries, and disciplines by a panel of independent judges during the Bentley Systems 2026 Year in Infrastructure Event, held October 6-7 in Singapore.

Cate Lochead, chief marketing officer at Bentley Systems, said, “Every year, our users impress us with incredible projects that advance the world’s infrastructure. This year’s finalists went well beyond digitalizing traditional workflows. By connecting data across lifecycle phases and engineering disciplines, they used AI to unlock potential that was previously out of reach. That new cycle of AI-enabled innovation requires an open ecosystem, where infrastructure professionals can connect their data and preferred software to make better, faster decisions. Bentley enables that openness, giving engineers the freedom to solve complex challenges faster and build a more resilient, sustainable future.”

Winners of the Year in Infrastructure 2026 Awards

Bridges and Tunnels

AYESA Engineering (Portugal): Porto Metro 3.0: Optimized Integrated Digital Tunnel Design Workflow

Cities and Facilities

Pinnacle Future Build Pvt. Ltd. (India): Pinnacle Infotech Digital Twin Madurai Campus

Construction

Wills Bros (Ireland): Dublin Port MP2 Berth 52 and 53

Energy Production

South-to-North Water Diversion (Chongqing) New Energy Development Co, Ltd and POWERCHINA Zhongnan Engineering Corporation Limited. (China): Chongqing Yunyang Jianquan Pumped Storage Digital Power Station

Geospatial and Reality Modeling

Aboitiz Renewables Inc. (Philippines): GeoShield

Project Delivery

Port Polska (Poland): Port Polska

Rail and Transit

SUDOP PRAHA a.s. (Czech Republic): HSR Central Bohemia (RS 1 VRT Poricany – Svetla nad Sazavou)

Roads and Highways

Torrens to Darlington Alliance (John Holland, Bouygues, Arcadis, Jacobs, Ventia) in partnership with the South Australian Government, Department for Infrastructure and Transport (Australia): River Torrens to Darlington (T2D) Project

Structural Engineering

PT Wijaya Karya Bangunan Gedung Tbk (WIKA Gedung) (Indonesia): Jakarta International Stadium – Engineering Largest Retractable Roof

Subsurface Modeling and Analysis

Intertechne Consultores S.A. (Brazil): Leapfrog and PLAXIS for Tailings Dam Modeling and Assessment

Transmission and Distribution

APD Global (Australia): Clean Energy Link-North: AI-Driven Digital Delivery for Renewables

Water and Wastewater

Evides N.V. (Netherlands): Water Distribution Operational Digital Twins at Scale

Founders’ Honors

Bentley also recognized 17 projects with Founders’ Honors. Chosen personally by Bentley’s founders and executives, Founders’ Honors are presented to a select number of stand-out projects, individuals, and organizations that reflect the company’s purpose of advancing the world’s infrastructure for better quality of life.

The 2026 Founders’ Honors recipients are:

Asset Intelligence

Empresas Públicas de Medellín (Colombia): EPM Water Secondary Distribution System Digital Twin

Connected Data

WSP Global Inc. (India): iTwin AI Project Lifecycle Intelligence Platform

Constructioneering

PT Hutama Karya (Persero) (Indonesia): The Parliamentary Complex of Nusantara

Design Optimization

POWERCHINA Fujian Electric Power Survey and Design Institute Co., Ltd. (China): Automatic Modeling and Optimization Software for Offshore Jacket Structures

Digital Champion

COBA - Consultores de Engenharia e Ambiente (Portugal): Santos Station – Extension of Lisbon Metro Yellow and Green Lines

Digital Infrastructure

Ampirical (United States): Powering the Western Hemisphere's Largest Data Center

Digital Twin at Scale

Almondz Global Infra Consultant Limited (India): NAKSHA

Education - Excellence in Hands-on Teaching using AI

Universidad de las Fuerzas Armadas ESPE (Ecuador): Intelligent Leak Management with Autoencoders

Education - Excellence in Teaching System of Systems Thinking

University of Glasgow - Smart Systems Group (United Kingdom): Glasgow City Region: Cocreation of Transport and Multi-Energy Futures

Ground-Informed Design

T.Y.Lin International Pte. Ltd. (Singapore): North-South Corridor – 800m Long Dual 3-Lane Road Tunnel

Model-Based Delivery

WSP USA Inc. (United States): I-35 Capital Express Central – Downtown (CapEx Central)

Resilience / Sustainability — Powering Tomorrow's Mobility

Fs Engineering S.p.A. (Italy): Energy Sustainability: Self-Production for Green Mobility System

TTC (Brazil): Electromobility in the Southern Region

Resilience / Sustainability — Restoring our Environment

Norconsult Norge AS (Norway): Mongstad Refinery – Contaminated Groundwater Risk and Mitigation Review

Resilience / Sustainability — Resilient Cities

Communauté d’Agglomération Pau Bearn Pyrénées – CAPBP (France): Urban Data Intelligence: A CDE for Climate Resilient Infrastructure

Resilience / Sustainability — Securing our Water Future

Maynilad Water Services, Inc. (Philippines): Scaling Leak Detection at Maynilad from DMA to System‑Wide Analysis

For more information about the 2026 Year in Infrastructure Awards, visit Bentley’s Year in Infrastructure website.

# # #

About Bentley Systems

Around the world, infrastructure professionals rely on software from Bentley Systems to help them design, build, and operate better and more resilient infrastructure for transportation, water, energy, cities, and more. Founded in 1984 by engineers for engineers, Bentley is the partner of choice for engineering firms and owner-operators worldwide, with software that spans engineering disciplines, industry sectors, and all phases of the infrastructure lifecycle. Through our digital twin solutions, we help infrastructure professionals unlock the value of their data to transform project delivery and asset performance.

© 2026 Bentley Systems, Incorporated. Bentley, the Bentley logo, iTwin, Leapfrog, and PLAXIS, are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. Other brands and product names are trademarks of their respective owners.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261007964087/en/

Permalink

https://www.aetoswire.com/en/news/54617927

Contacts

For more information, contact:

Bentley Press: Michaela Romero, PR@news.bentley.com

Bentley Investors: Eric Boyer, IR@bentley.com    

Gaétane Baudry Appointed Senior Vice President/Global General Manager, Bobbi Brown

 

NEW YORK - 

(BUSINESS WIRE)--The Estée Lauder Companies Inc. (NYSE: EL) today announced the appointment of Gaétane Baudry as Senior Vice President/Global General Manager, Bobbi Brown, effective October 8, 2026. Based in New York, she will report to Lisa Sequino, Global President, Makeup Brands.

In this role, Gaétane will lead Bobbi Brown’s global strategy and continued evolution, strengthening the brand’s distinctive equity, advancing innovation and creativity, and deepening consumer engagement around the world.

“Gaétane is an inspiring and highly collaborative leader who brings experience, energy and a strong focus on execution,” said Lisa Sequino, Global President, Makeup Brands. “Her global brand-building record, strong commercial leadership and passion for creating meaningful consumer experiences will be invaluable as Bobbi Brown builds on its unique brand equity focused on effortless natural beauty, while accelerating its digital evolution, moving into new channels and deepening its ability to connect with women around the world. I am excited to welcome her to The Estée Lauder Companies and look forward to all that Gaétane and the Bobbi Brown team will accomplish together.”

Gaétane is a global luxury beauty executive with more than two decades of experience building brands, leading transformations and driving growth across international markets. She was most recently Global Brand President of Shu Uemura at L’Oréal Luxe, where she oversaw the brand’s marketing, communications, retail, e-commerce, education and business development activities.

During her time at Shu Uemura, Gaétane redefined the brand platform and category strategy, strengthened its cultural relevance and advanced its retail and omnichannel experience. Under her leadership, the brand achieved a top position among makeup artist brands in Asia, gained prestige beauty share in highly competitive markets and increased its online business. Earlier in her career, she held senior leadership roles at Giorgio Armani Beauty, Helena Rubinstein and Lancôme, building expertise across luxury beauty, makeup, innovation, consumer engagement and global brand strategy.

With a distinctive heritage, powerful point of view and globally beloved products, Bobbi Brown is well-positioned to deepen its connection with women around the world. Gaétane will build on these strengths by sharpening the brand’s expression, enhancing its relevance across markets and creating compelling experiences for today’s consumers, while preserving the effortless authenticity at the heart of Bobbi Brown.

About The Estée Lauder Companies

The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers, and sellers of quality skin care, makeup, fragrance, and hair care products, and is a steward of luxury and prestige brands globally. The company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, the DECIEM family of brands, including The Ordinary, NIOD, Avestan and Loopha, and Balmain Beauty.

ELC-L

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261008525584/en/

Permalink

https://aetoswire.com/en/news/54618202

Contacts

Media Relations:

Brendan Riley

briley@estee.com

Investor Relations:

Rainey Mancini

rmancini@estee.com

 

SLB Awarded Digital Drilling Contract by TotalEnergies

 Deployment will connect subsurface insights with well engineering and drilling planning workflows

 

(BUSINESS WIRE)--Global energy technology company SLB (NYSE: SLB) today announced a 15-year agreement with TotalEnergies to use the DrillPlan™ coherent well planning and engineering solutions. The agreement will support TotalEnergies’ transition to a digital planning environment, connecting subsurface insights with well planning and engineering.

Enabled by SLB’s DrillPlan solutions and the expertise of both companies, the agreement marks a significant step in the companies’ digital collaboration and reflects a broader shift across the industry as operators move toward scalable, interoperable digital platforms to improve engineering and well construction execution.

The DrillPlan solutions will enable TotalEnergies to streamline well design and engineering activities by integrating offset well data, trajectory designs, casing and completion inputs, and planning assumptions used throughout the well construction process, enabling cross-functional teams to work from a common foundation of data, plans and assumptions.

“Operators are increasingly looking for scalable technologies that can support more consistent planning decisions across large and diverse portfolios,” said Rakesh Jaggi, president of SLB’s Digital business. “This agreement demonstrates how customers are moving toward digital solutions that improve consistency, strengthen collaboration and provide a foundation for future workflow innovation.”

Drawing on domain expertise from both companies, the environment is designed to connect workflows, integrate custom processes, scale across operations, and enable ongoing deployment of new digital technologies.

Built on SLB’s strengths in well construction and digital technology, the DrillPlan solutions help integrate established customer workflows within a broader enterprise digital ecosystem. The agreement reflects a growing industry focus on combining the domain expertise embedded in internally developed digital solutions with the scale, resilience and interoperability of commercial platforms.

Key Points:

SLB has been awarded an agreement by TotalEnergies to deploy the DrillPlan™ coherent well planning and engineering solutions across its global upstream portfolio.

The deployment will connect subsurface insights with well planning and engineering, supporting a standardized digital drilling planning environment.

DrillPlan solutions integrate offset well data, trajectory designs, casing and completion inputs, and planning assumptions used throughout the well construction process.

The agreement supports an approach that combines established customer workflows and internally developed digital expertise with SLB’s well construction and digital domain expertise.

The agreement builds on the long-standing collaboration between SLB and TotalEnergies and supports continued innovation in digital well construction planning.

About SLB

SLB (NYSE: SLB) is a global technology company that has driven energy innovation for 100 years. With a global footprint in more than 100 countries and employees representing almost twice as many nationalities, we work each day on innovating oil and gas, delivering digital at scale, decarbonizing industries, and developing and scaling new energy systems that accelerate the energy transition. Find out more at slb.com.

Cautionary Statement Regarding Forward-Looking Statements:

This press release contains “forward-looking statements” within the meaning of the U.S. federal securities laws — that is, statements about the future, not about past events. Such statements often contain words such as “expect,” “may,” “can,” “estimate,” “intend,” “anticipate,” “will,” “potential,” “projected" and other similar words. Forward-looking statements address matters that are, to varying degrees, uncertain, such as forecasts or expectations regarding the deployment of, or anticipated benefits of, SLB’s new technologies and partnerships; and improvements in operating procedures and technology. These statements are subject to risks and uncertainties, including, but not limited to, the inability to recognize intended benefits of SLB’s strategies, initiatives or partnerships; and other risks and uncertainties detailed in SLB’s most recent Forms 10-K, 10-Q and 8-K filed with or furnished to the U.S. Securities and Exchange Commission. If one or more of these or other risks or uncertainties materialize (or the consequences of such a development changes), or should underlying assumptions prove incorrect, actual outcomes may vary materially from those reflected in our forward-looking statements. The forward-looking statements speak only as of the date of this press release, and SLB disclaims any intention or obligation to update publicly or revise such statements, whether as a result of new information, future events or otherwise.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261008482170/en/

Permalink

https://aetoswire.com/en/news/54617998

Contacts

 

Media

Josh Byerly – SVP of Global Communications

Moira Duff – Director of External Communications

SLB

Tel: +1 (713) 375-3407

media@slb.com

Investors

James R. McDonald – SVP of Investor Relations & Industry Affairs

Joy V. Domingo – Director of Investor Relations

SLB

Tel: +1 (713) 375-3535

investor-relations@slb.com

 

Bacardi Climbs to #32 Among the World’s Top Companies for Women

 Family-owned Bacardi is highest-ranked spirits company

 

(BUSINESS WIRE)--Bacardi Limited has climbed to #32 on the Forbes list of the World’s Top Companies for Women 2026, rising from #60 the previous year and earning a place on the prestigious global ranking for the fifth consecutive year. The family-owned company is the highest-ranked spirits company on this year’s list and ranks #2 in the “Food, Soft Beverages, Alcohol & Tobacco” category. The recognition reflects a continued commitment to creating opportunities, championing career development and cultivating a workplace where people feel valued, empowered and able to do their best work.

“The most meaningful measure of our progress is seeing talented women choose to join Bacardi, build their careers here and advance into leadership roles,” says Nicole Zukowski, Chief Supply Chain Officer and Executive Sponsor of the Bacardi Limited Good Spirited Corporate Sustainability initiative. “At Bacardi, we're committed to providing opportunities, championing development and fostering a culture where people feel they belong, because when our people flourish, so does our business.”

Among some of the many ways Bacardi supports the development of women both inside and outside the company are:

Advancing leadership: Women hold 45% of leadership positions (manager and above) at Bacardi. The company also reports gender equity across recruitment, turnover, pay and engagement.

Investing in development: Bacardi maintains balanced representation in its core development programs, helping talent build the skills and experience needed to advance their careers.

Strengthening industry connections: Bacardi participates in organizations that support female talent, including Women of the Vine & Spirits, Women Leading Rum & Spirits, the OurWhisky Foundation and the LEAD Network.

Supporting economic independence: In the United States, Bacardi supports Dress for Success Miami, which provides skills, tools and professional attire to help people secure employment and achieve financial independence.

Opening doors to hospitality careers: In India, Bacardi hosts a women-only cohort of Shake Your Future, its free bartending program, to encourage more women to pursue opportunities in the hospitality and drinks industry. This complements other Shake Your Future cohorts in the market which are open to all.

Building awareness and support: In the United Kingdom, a network of Menopause Champions leads conversations and builds awareness for those experiencing menopause and the people who support them.

To create the list, Forbes partnered with market research firm Statista to survey approximately 140,000 women working for multinational corporations across 61 countries. Surveys were conducted primarily through anonymous, independent online panels, allowing participants to answer freely. Access details and the complete 2026 list here.

Bacardi was also recently named by Forbes among 2026 World’s Best Employers, where it took the top spot among pure spirits companies, and Fortune 100 Best Companies to Work for in Europe 2026.

About Bacardi Limited

Bacardi Limited, the world’s largest privately held international spirits company, produces, markets, and distributes spirits and wines. The Bacardi Limited portfolio comprises more than 200 brands and labels, including BACARDÍ® rum, PATRÓN® tequila, GREY GOOSE® vodka, DEWAR’S® Blended Scotch whisky, BOMBAY SAPPHIRE® gin, MARTINI® vermouth and sparkling wines, CAZADORES® 100% blue agave tequila, and other leading and emerging brands including D’USSÉ® Cognac, ANGEL’S ENVY® American straight whiskey, and ST-GERMAIN® elderflower liqueur. Founded more than 164 years ago in Santiago de Cuba, family-owned Bacardi Limited currently employs more than 7,000, operates production facilities in 10 countries and territories, and sells its brands in more than 160 markets. Bacardi Limited refers to the Bacardi group of companies, including Bacardi International Limited. Visit http://www.bacardilimited.com or follow us on LinkedIn or Instagram.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261008127263/en/

Permalink

https://aetoswire.com/en/news/54617863

Contacts

 

Media Contacts:

Jessica Merz, VP Global Corporate Communications

jmerz@bacardi.com

 

Armenia Grants First Marketing Authorizations for Agenus’ BOT+BAL in Previously Treated MSS Metastatic Colorectal Cancer

 Botvymo® (botensilimab) and Evamplix® (balstilimab) receive separate approvals for use in combination

Armenia is the first country to approve marketing authorization of BOT+BAL, following a rigorous review of quality, nonclinical, clinical and pharmacovigilance data

Approvals supported by clinical evidence published in peer-reviewed journals and presented at major oncology congresses, including two-year Phase 1b survival findings and randomized Phase 2 data in MSS metastatic colorectal cancer without active liver metastases

Agenus will evaluate the potential for approvals in other Eurasian Economic Union countries that support this regulatory path

 

(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the Ministry of Health of the Republic of Armenia has granted marketing authorizations for Botvymo® (botensilimab, BOT) and Evamplix® (balstilimab, BAL), each approved for use in combination with the other for the treatment of adult patients with microsatellite stable (MSS) metastatic colorectal cancer (mCRC) without active liver metastases who have previously received available standard therapies. These are the first marketing authorizations for either medicine anywhere in the world. The approvals are expected to benefit patients in Armenia as well as patients who travel to Armenia for treatment under the care of Armenian oncologists.

Botensilimab is a multifunctional, Fc-enhanced anti-CTLA-4 antibody designed to activate innate and adaptive antitumor immune responses, including in tumors that have historically responded poorly to conventional immunotherapy. Balstilimab is an anti-PD-1 antibody designed to sustain antitumor T-cell activity.

The approvals are effective as of October 2, 2026. They follow a rigorous review by Armenia’s regulatory authorities of the complete registration dossier, submitted in the international Common Technical Document format used under Eurasian Economic Union rules. The review covered product quality and manufacturing (chemistry, manufacturing and controls), nonclinical data, clinical efficacy and safety data, and the pharmacovigilance system and risk management plan. BOT and BAL were separately submitted and approved for use as a combination regimen. Under the approved product information, Botvymo is administered at 75 mg intravenously every 6 weeks for up to 4 doses, in combination with Evamplix at 240 mg intravenously every 2 weeks for up to 2 years or until disease progression or unacceptable toxicity.

Each marketing authorization is conditional and valid for one year and is renewable based on the clinical updates that Agenus will provide to the Armenian regulator each year.

“Armenia is the first country in the world to grant marketing approval for BOT+BAL,” said Garo H. Armen, PhD, Chairman and Chief Executive Officer of Agenus. “The evidence behind this decision has been published in peer-reviewed journals and presented at major cancer conferences, and it has consistently pointed to clinical benefit for patients with metastatic colorectal cancer. We thank Armenia’s health authorities for the depth and care of their review. Patients who have exhausted standard treatments now have a new option, and we are proud to bring it to them.”

Clinical Evidence Supporting the Approvals

The Armenian approvals were based on the totality of clinical evidence for BOT+BAL in MSS mCRC, including mature results from the fully enrolled MSS mCRC patient cohort from the Phase 1b C-800-01 study and data from the randomized Phase 2 C-800-25 study. Results from this clinical program have been published in peer-reviewed journals, including Nature Medicine and Clinical Cancer Research, and presented at major oncology congresses, including the ASCO Gastrointestinal Cancers Symposium. The efficacy and safety data supporting the approvals are summarized in the approved product information for Botvymo and Evamplix.

Regional Opportunities

Following the Armenian approvals, Agenus will evaluate the potential to seek marketing authorizations for BOT+BAL in the MSS metastatic colorectal cancer setting in other Eurasian Economic Union member countries.

Access to BOT+BAL Outside Armenia

The Armenian marketing authorizations apply within the territory of Armenia.

In France, the national Autorisation d’Accès Compassionnel (AAC) program provides fully reimbursed, hospital-based access to BOT+BAL for eligible patients with MSS metastatic colorectal cancer without active liver metastases, platinum-resistant or platinum-refractory ovarian cancer, and certain advanced soft-tissue sarcomas. In a growing number of other countries, BOT+BAL is available through physician-initiated named-patient programs under local regulations. BAP Pharma serves as Agenus’ global partner for the French AAC pathway and named-patient access programs.

Physicians seeking information about authorized access pathways can visit the Patient Access section of our corporate website.

Important Safety Information

The approved product information for Botvymo and Evamplix includes warnings and precautions for immune-mediated adverse reactions, including colitis and diarrhea, hepatitis, pneumonitis, endocrinopathies, nephritis, myocarditis and pancreatitis, as well as infusion-related reactions. Healthcare professionals in Armenia should consult the approved product information before prescribing.

About Agenus

Agenus is a leading immuno-oncology company targeting cancer with a comprehensive pipeline of immunological agents. The company was founded in 1994 with a mission to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants. Agenus has robust end-to-end development capabilities, across commercial and clinical cGMP manufacturing facilities, research and discovery, and a global clinical operations footprint. Agenus is headquartered in Lexington, MA. For more information, visit www.agenusbio.com or @agenus_bio. Information that may be important to investors will be routinely posted on our website and social media channels.

About Botensilimab (BOT)

Botensilimab (BOT) is a human multifunctional, Fc-enhanced anti-CTLA-4 antibody designed to boost both innate and adaptive anti-tumor immune responses. Its novel design leverages mechanisms of action to extend immunotherapy benefits to “cold” tumors which generally respond poorly to standard of care or are refractory to conventional PD-1/CTLA-4 therapies and investigational therapies. BOT augments immune responses across a wide range of tumor types by priming and activating T cells, reducing intratumoral regulatory T cells, activating myeloid cells and inducing durable memory responses.

BOT+ balstilimab (BAL) has been studied in over 1,500 patients across more than nine tumor types, spanning late-line refractory disease and early-stage neoadjuvant settings. The combination is being developed to expand immunotherapy benefit to more patients, including those with microsatellite stable (MSS) disease and tumors considered immunologically “cold” or resistant to existing immunotherapies. Agenus’ Phase 3 ROBBIN study is designed to evaluate BOT+BAL given before surgery in earlier-stage colon cancer.

For more information about botensilimab trials, visit www.clinicaltrials.gov.

About Balstilimab (BAL)

Balstilimab is a novel, fully human monoclonal immunoglobulin G4 (IgG4) designed to block PD-1 (programmed cell death protein 1) from interacting with its ligands PD-L1 and PD-L2. It has been evaluated in more than 900 patients to date and has demonstrated clinical activity and a favorable tolerability profile in several tumor types.

Botvymo and Evamplix are authorized in Armenia for use in combination for the treatment of previously treated MSS metastatic colorectal cancer without active liver metastases. Their use in other indications and in other countries remains investigational.

Forward-Looking Statements

This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the federal securities laws, including statements regarding its botensilimab and balstilimab programs, the conditional Armenian marketing authorizations and their renewal, the availability of treatment to patients who travel to Armenia, potential regulatory submissions in other countries, expected regulatory timelines and filings, and any other statements containing the words "may," "believes," "expects," "anticipates," "hopes," "intends," "plans," "forecasts," "estimates," "will," “establish,” “potential,” “superiority,” “best in class,” and similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include, among others, the factors described under the Risk Factors section of our most recent Annual Report on Form 10-K for 2025, and subsequent Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission. Agenus cautions investors not to place considerable reliance on the forward-looking statements contained in this release. These statements speak only as of the date of this press release, and Agenus undertakes no obligation to update or revise the statements, other than to the extent required by law. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261008022628/en/

Permalink

https://www.aetoswire.com/en/news/54618112

Contacts

Investors

917-362-1370 | investor@agenusbio.com

Media

781-674-4422 | communications@agenusbio.com

Fortune Media and Great Place To Work Name Experian As One Of The ‘100 Best Companies to Work For Europe’ in 2026 for Second Year

LONDON - Thursday, 08. October 2026

(BUSINESS WIRE) -- Great Place To Work® and Fortune Europe have recognised Experian as one of the Fortune 100 Best Companies to Work For™ Europe for the second-year running.

The 100 Best Companies to Work For Europe list is a comprehensive recognition for business excellence and employee experience, based on Great Place To Work’s proprietary Trust Index™ Survey. Great Place To Work evaluates confidential feedback from employees, validating against HR data from participating companies. Only companies with consistently high survey responses from employees — regardless of their role, department, or status in the company — are honored with placement on the list.

Eligible companies have 500 or more employees and were represented on at least one national Best Workplaces™ List in Europe.

Jacky Simmonds, Chief People Officer, Experian, said: “We are thrilled to being named one of the Fortune 100 Best Companies to Work For™ in Europe for the second year in a row. It’s an incredibly proud moment for us at Experian, where we’ve striven to build a culture where people feel valued, supported, and inspired. This recognition belongs to our teams who bring their passion and commitment to bettering people’s financial wellbeing every day.”

Since it first began working with Great Place to Work in 2021, Experian has continued building on its commitment to employees through a collaborative and inclusive culture.

Reasons for Experian being recognised this year include:

    An inclusive and welcoming culture, which empowers employees to feel included and part of a team, as well as being able to bring their full self to work

    Flexibility and trust in employees and colleagues, facilitating better and more innovative work

    Dedication to delivering purposeful work that has a direct and positive societal impact

Earning a spot on the list is an indicator of high levels of trust across the organisation, with more employees reporting a consistently positive experience at work.

“Congratulations to the 100 Best in Europe,” says Michael C. Bush, CEO of Great Place To Work. “From across the continent, these companies are the most trusted by their people, and in turn enjoy higher levels of agility, innovation, and performance.”

“In a year of non-stop disruption, these companies didn't retreat to old formulas; they doubled down on trust,” says Grethe Schepers, lists director, Europe at Fortune. “Congratulations to every workplace on our list for proving that a people-first culture is your greatest asset for navigating change.”

Notes to editors:

Methodology:

Eligible companies have 500 or more employees and were represented on at least one national Best Workplaces™ List published by Great Place To Work in Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, the Netherlands, Norway, Poland, Portugal, Spain, Sweden, Switzerland, Türkiye, and the United Kingdom during 2025 or early 2026.

About Experian

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and platforms. We also assist millions of people to realise their financial goals and help them to save time and money.

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 25,200 people across 33 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

About the Fortune 100 Best Companies to Work For Europe

Great Place To Work selected the 100 Best list by gathering and analyzing more than 1.5 million confidential survey responses representing the experiences of over 2.4 million employees in the region. Of those, 1.2 million responses came from companies eligible for this list, and this ranking is based on that feedback. Companies must be Great Place To Work Certified™, have 500 employees or more, and be recognized on at least one national Best Workplaces list in Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, the Netherlands, Norway, Poland, Portugal, Spain, Sweden, Switzerland, Türkiye, and the United Kingdom during 2025 or early 2026. Organizations are assessed on their efforts to create generous, supportive, high-performance work experiences for every employee in the organization.

About Great Place To Work

As the global authority on workplace culture, Great Place To Work, a UKG company, brings 30 years of groundbreaking research and data to help every place become a great place to work for all. Its proprietary platform and Great Place To Work Model help companies evaluate the experience of every employee, with exemplary workplaces becoming Great Place To Work Certified and receiving recognition on a coveted Best Workplaces list.

Follow Great Place To Work on LinkedIn, X, and Instagram, and sign up for the Great Place To Work LinkedIn newsletter, Culture Edge, to get the latest research on what drives business success.

About Fortune Media

Fortune is a global multi-platform media company built on a legacy of trusted, award-winning reporting and information for those who want to make business better. Independently owned, Fortune tells the stories of the world's biggest companies and their leaders as well as a new generation of innovators who are moving business forward. Digitally and in print, Fortune measures corporate performance through rigorous benchmarks and holds companies accountable in regions around the world. Its iconic rankings include Fortune 500, Fortune Global 500, Most Powerful Women, and World's Most Admired Companies. Fortune builds world-class communities by convening industry thought leaders for exclusive summits and conferences, including the Fortune Global Forum, Fortune Brainstorm Tech, and Fortune Most Powerful Women. For more information, visit fortune.com.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261008229836/en/

Permalink
https://www.aetoswire.com/en/news/0810202657916

Contacts

Media contact:
Ashley Jenkins, Corporate Communications Manager, UK&I, Experian
Tel: +44 7483 609414 / Email: ash.jenkins@experian.com

The LYCRA Company to Spotlight Renewable LYCRA® Fiber and Textile-to-Textile Circularity at Textile Exchange Conference 2026

 WILMINGTON, Del. - Thursday, 08. October 2026 AETOSWire Print 

(BUSINESS WIRE)--The LYCRA Company, a global leader in fiber and technology solutions for the apparel and personal care industries, will showcase Renewable LYCRA® fiber and its work to advance textile-to-textile recycling at Textile Exchange Conference 2026. The conference takes place October 12–16, at the Vancouver Convention Centre in Vancouver, Canada.

This year's theme, "The Implementation Era," focuses on scaling what works across businesses, supply systems, and landscapes. At the conference, The LYCRA Company will highlight its work with partners across the value chain, helping to shape the future for textiles through renewable fiber solutions, circular innovation, and strategic industry partnerships.

“Bringing more recycled and renewable materials to commercial scale is essential to turning the industry’s ambitions into action,” said Alistair Williamson, vice president of product sustainability at The LYCRA Company. “At Textile Exchange, we’ll feature how Renewable LYCRA® fiber is making that progress possible today, while delivering the stretch, fit and comfort consumers expect.”

Renewable LYCRA® fiber is made with 70% plant-based content using U.S.-grown dent corn as a key feedstock and is now being produced at commercial scale. The corn is sourced largely from Iowa, replacing a significant portion of the petroleum-derived inputs traditionally used to make spandex. A third-party-reviewed life cycle assessment shows the fiber can reduce its carbon footprint by up to 45%* while maintaining equivalent stretch and recovery performance.

Over the last few years, The LYCRA Company has also worked with textile recyclers worldwide to build and refine systems that separate spandex from companion yarns, such as nylon and polyester, from pre-consumer textile waste, and spin it back into new spandex fibers. The result is a pilot-stage spandex recycling system and an important step toward textile circularity. The next step is scaling up the infrastructure to produce LYCRA® fiber made with recycled content.

“Creating commercially viable textile-to-textile recycling systems requires collaboration, and we are helping advance technologies designed to recover and reclaim spandex from end-of-life textiles,” Williamson added.

The LYCRA Company team will be available throughout the conference at booth #18 to talk with brands, mills, and industry stakeholders about renewable and circular solutions and discuss opportunities for collaboration, sourcing and product development.

About The LYCRA Company

The LYCRA Company innovates and produces fiber and technology solutions for the apparel and personal care industries and owns the leading consumer brands: LYCRA®, LYCRA HyFit®, LYCRA® T400®, COOLMAX®, THERMOLITE®, ELASPAN®, SUPPLEX® and TACTEL®. Headquartered in Wilmington, Delaware, United States, The LYCRA Company is recognized worldwide for its high-quality products, technical expertise, and marketing support. The LYCRA Company focuses on adding value to its customers’ products by developing unique innovations designed to meet the consumer’s need for comfort and lasting performance. Learn more at thelycracompany.com.

*Comparative Life Cycle Assessment: LYCRA® fiber with Bio-derived PTMEG vs. LYCRA® fiber with Fossil-Derived PTMEG, Ramboll, 2026​

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261008178765/en/

Permalink

https://www.aetoswire.com/en/news/54618149

Contacts

Karie J. Ford

Karie.j.ford@lycra.com

 

NIQ Reaches Key Milestone in Acquisition of The U Group, Strengthening Trusted Intelligence and The Full View™

 CHICAGO - Thursday, 08. October 2026

(BUSINESS WIRE) -- NielsenIQ (NYSE: NIQ) today announced that its wholly-owned Australian subsidiary, Nielsen Connect Australia Pty Ltd (NIQ Australia), has exceeded the 90% shareholder acceptance threshold under its off-market takeover bid for The U Group & Co Limited (The U Group), an Australian-based company specializing in consumer participation, receipt intelligence, and AI-powered data processing capabilities.

Achieving the acceptance threshold represents a significant milestone in the transaction process and enables NIQ Australia to proceed with the compulsory acquisition of the remaining shares in The U Group in accordance with applicable Australian law.

Building on a successful five-year partnership, the transaction strengthens NIQ's trusted intelligence foundation and advances its strategy to deliver the industry's most complete understanding of consumer buying behavior. By bringing together NIQ's measurement, analytics, and consumer intelligence capabilities with The U Group's consumer participation, receipt intelligence, and AI-powered technologies, including its ReceiptJar application, NIQ will further enhance The Full View™ and expand access to real-world consumer purchasing behavior.

The combination will strengthen NIQ's consumer intelligence capabilities, complementing existing consumer panel and Homescan solutions with differentiated, consumer-consented purchase signals and receipt-based insights. Together, these capabilities provide a more connected view of consumer behavior and create new opportunities for innovation, measurement, and client value.

“Every new way to shop creates a new measurement challenge for brands and retailers,” said Troy Treangen, Chief AI and Product Officer of NIQ. “The U Group’s receipt intelligence and AI-powered technologies will help us strengthen our consumer panels and give clients a clearer view of purchasing behavior across channels, including the emerging agentic commerce channel. As AI agents increasingly influence what people buy, connecting those decisions to actual purchases becomes essential. This combination strengthens The Full View™ and the data foundation we need to build the next generation of consumer intelligence.”

The transaction also reflects NIQ's continued commitment to investing in differentiated data, technology, and capabilities that drive growth and innovation for clients around the world.

The compulsory acquisition process and other remaining steps required to complete the transaction are expected to proceed in accordance with Australian legal requirements.

About NIQ

NielsenIQ (NYSE: NIQ) is a leading consumer intelligence company, delivering the most complete and trusted understanding of consumer buying behavior and revealing new pathways to growth. By combining an unmatched global data footprint and granular consumer and retail measurement with decades of AI modeling expertise, NIQ builds decision systems that help companies turn complex data into confident action.

With operations in more than 90 countries, NIQ covers approximately 82% of the world's population and more than $7.4 trillion in global consumer spend. Through cloud-based platforms, advanced analytics and AI-driven insights, NIQ delivers The Full View™, helping brands and retailers understand what consumers buy, why they buy it, and what to do next.

For more information, visit NIQ.com.

NIQ-IR

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261008523221/en/

Permalink

https://www.aetoswire.com/en/news/54617988

Contacts

Media

media.relations@nielseniq.com

Almarai Company Presents Its 2026–2031 Growth Strategy to the Business Community

  Riyadh, Saudi Arabia - Thursday, 08. October 2026 AETOSWire 

Almarai presented its new strategy during its Capital Markets Day in Riyadh where company executives engaged with investors, bankers, analysts and members of the wider business community.

Almarai is planning to deploy more than USD 4 billion over the strategy period to support capacity expansion, strengthen its capabilities, and enable the next phase of sustainable growth.

 

Almarai Company, the world’s largest vertically integrated dairy company and the largest food and beverage manufacturing and distribution company in MENA, today unveiled details of its 2026–2031 strategy to the business community at its Capital Markets Day 2026.

The strategy sets out four priorities for the Company’s next phase of growth: strengthening its core categories, expanding selectively into promising new categories, growing in channels such as foodservice and e-commerce, and expanding in priority markets. The strategy builds on decades of investment in brands, manufacturing, supply chains, and people, and reflects the Company’s ambition to create sustainable value for consumers, customers, employees, shareholders, and the communities it serves.

This ambition is underpinned by a significant investment program, with Almarai planning to deploy more than USD 4 billion over the strategy period to support capacity expansion, strengthen its capabilities, and enable the next phase of sustainable growth.

Commenting on the strategy, Fawaz Aljasser, Chief Executive Officer of Almarai Company, said:

“Our new growth strategy is supported by our trusted brands, industry-leading capabilities, and one of the region’s most integrated food and beverage platforms. Today, we are entering the next phase of our journey from a position of strength.

Importantly, our ambition extends beyond financial performance. We are investing to broaden consumer choice, enhance supply chain resilience, and strengthen local manufacturing.

We believe that Almarai’s combination of trusted brands, operational excellence, scale, and resilience positions us well to capture the significant opportunities while continuing to deliver the quality and value that consumers expect.”

The new opportunities Almarai aims to capture are driven by long-term growth trends across the food and beverage sector, increasing consumer demand for high-quality products, and the Company’s differentiated capabilities spanning manufacturing, supply chain, distribution, consumer-centricity, and innovation.

Permalink

https://www.aetoswire.com/en/news/0810202657918

Contacts

Abdulrahman Alafalig

abdulrahman.alafalig@almarai.com

Andersen Consulting Adds TalentSmartEQ to Advance Leadership and Business Transformation

 SAN FRANCISCO - Thursday, 08. October 2026 AETOSWire  

(BUSINESS WIRE) -- Andersen Consulting expands its human capital capabilities through a Collaboration Agreement with TalentSmartEQ, a San Diego-based firm focused on creating practical, engaging and actionable learning experiences rooted in emotional intelligence (EQ) and leadership development.

For more than two decades, TalentSmartEQ has worked with organizations around the world to develop leadership skills through emotional intelligence, helping strengthen employee engagement, teamwork, and overall performance. The firm combines research-based methodology with practical learning experiences, assessments, coaching, and customized programs that are designed to translate EQ development into sustained changes in workplace behavior. As an industry leader, TalentSmartEQ works with organizations spanning Fortune 500 companies to government agencies and privately held businesses.

“Organizations are asking more of their leaders and employees as the workplace continues to evolve,” said Howard Farfel, CEO of TalentSmartEQ. “We focus on turning the research behind emotional intelligence into practical tools people can easily understand and apply. Our collaboration with Andersen Consulting represents an exciting next step, allowing us to build on that foundation and reach organizations seeking more effective ways to develop their people and improve workplace culture and organizational performance.”

“Technology and business transformation may change how organizations operate, but people remain central to whether those changes succeed,” said Mark L. Vorsatz, global chairman and CEO of Andersen. “TalentSmartEQ’s work in emotional intelligence, leadership, and team performance complements our broader transformation capabilities and adds a valuable dimension to our work with organizations navigating change.”

Andersen Consulting is a global consulting practice providing a comprehensive suite of services spanning corporate strategy, business, technology, and AI transformation, as well as human capital solutions. Andersen Consulting integrates with the multidimensional service model of Andersen Global, delivering world-class consulting, tax, legal, valuation, global mobility, and advisory expertise on a global platform with more than 50,000 professionals worldwide and a presence in over 1,000 locations through its member firms and collaborating firms. Andersen Consulting Holdings LP is a limited partnership and provides consulting solutions through its member firms and collaborating firms around the world.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261008228417/en/

Permalink

https://www.aetoswire.com/en/news/0810202657934

Contacts

mediainquiries@Andersen.com

Fall Clinical 2026: Galderma Presents New Three-Year Nemluvio® Data Showing Deep and Lasting Skin Lesion and Itch Responses in Patients With Atopic Dermatitis Aged 12 and Older

 ZUG, Switzerland - 

New Nemluvio® (nemolizumab) post-hoc data from the ARCADIA long-term extension (LTE) study showed the majority of Week 16 responders maintained deep and lasting skin lesion and itch response for up to three years1

Additional long-term data further demonstrate Nemluvio’s consistent safety profile and sustained efficacy, including improvements in skin clearance, itch, sleep and quality of life in adults with prurigo nodularis up to 148 weeks, and people with atopic dermatitis aged 12 and older up to 152 weeks2,3

Phase II pediatric data will also be presented, with nemolizumab driving meaningful and sustained improvements in children aged 2-11 years with moderate-to-severe atopic dermatitis4

Alongside a product theatre exploring how targeted IL-31 treatment may impact patient outcomes, these findings reinforce Galderma's leadership in advancing treatment goals in atopic dermatitis and prurigo nodularis

 

(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, today announced new data regarding the use of Nemluvio for atopic dermatitis and prurigo nodularis to be presented at the 2026 Fall Clinical Dermatology Conference, taking place from October 08-11 in Las Vegas, United States. This includes a new post-hoc analysis from the ARCADIA LTE study showing that in adults and adolescents aged 12 and older who achieved an early response at Week 16 in the ARCADIA trial, Nemluvio achieved deep and lasting skin lesion and itch responses for up to three years.1 The data add to the growing evidence supporting the long-term efficacy of Nemluvio, underscoring Galderma's commitment to advancing the science for people living with moderate-to-severe atopic dermatitis and prurigo nodularis.

 

“Patients and physicians increasingly expect more from treatment than temporary symptom relief. The data presented at Fall Clinical reinforce our confidence in Nemluvio's potential to deliver durable disease control, with evidence spanning deep and sustained responses on skin and itch through three years in adults and adolescents, and a consistent long-term safety and efficacy profile. Together, these findings reflect Galderma's continued focus on redefining what is possible for people living with atopic dermatitis and prurigo nodularis.”

 

BILL ANDRIOPOULOS, PH.D.

HEAD OF GLOBAL MEDICAL AFFAIRS

GALDERMA

 

Majority of ARCADIA Week 16 early responders maintained deep and lasting skin lesion and itch responses with Nemluvio through three years1

New post-hoc data from the ongoing ARCADIA LTE study showed that adults and adolescents aged ≥12 years with moderate-to-severe atopic dermatitis who achieved an early clinical response with Nemluvio in the ARCADIA trials, were able to maintain deep and lasting improvements in both skin lesions and itch response through Week 152.1 The analysis evaluated 295 patients who achieved a clinical response at Week 16 and continued treatment during the maintenance and LTE phases of the study.1 Deep skin clearance was assessed by the proportion of participants achieving an IGA score of 0 or 1, and those with a more than 90% or 100% improvement from the initial baseline in the EASI score.1

Among these early responders at one year (Week 56), 77% achieved clear skin or at least a 90% improvement in disease severity.1 This was maintained up to Week 152, where 76% achieved clear (IGA 0) or almost clear skin (IGA 1), and 80% achieved at least a 90% improvement in disease severity (EASI-90) and 50% achieved complete skin clearance (EASI-100).1 In addition, at Week 152, 80% achieved an itch-free or nearly itch-free state.1

Nemluvio was well tolerated, with no new safety signals.1 The data are consistent with the previously collected safety and efficacy data regarding Nemluvio in adults and adolescents with moderate-to-severe atopic dermatitis.5 These findings further strengthen the growing body of evidence supporting the long-term efficacy of Nemluvio and its potential to deliver lasting disease control across key symptoms of atopic dermatitis.

 

“As progress in this high-burden disease area accelerates, we are challenged to aim higher in atopic dermatitis care. These new three-year results are encouraging for Nemluvio, adding to its growing body of evidence and highlighting its potential to help patients achieve meaningful long-term outcomes in atopic dermatitis.”

 

SARINA ELMARIAH, M.D.

DERMATOLOGIST AND ITCH SPECIALIST

UNIVERSITY OF CALIFORNIA

SAN FRANCISCO, UNITED STATES

 

Separate three-year interim analysis from the ARCADIA LTE reinforces the long-term benefit of Nemluvio2

A separate pre-specified interim analysis of the overall ARCADIA LTE population assessed the long-term safety and efficacy of Nemluvio in 1,903 adults and adolescents aged ≥12 years with moderate-to-severe atopic dermatitis.2 At Week 152, Nemluvio was well-tolerated and associated with sustained efficacy, including improvements in skin lesions, itch, sleep disturbance and quality of life.2 Based on observed case analyses:

Up to 91% of patients achieved at least 75% improvement in eczema severity (EASI-75), and up to 75% achieved at least 90% improvement in eczema severity (EASI-90)2

Up to 67% of patients achieved clear or almost clear skin (IGA 0/1)2

Up to 88% of patients achieved clinically meaningful itch relief and up to 73% achieved an itch-free or nearly itch-free state2

Up to 92% of patients achieved clinically meaningful improvements in dermatology-related quality of life2

The safety profile of Nemluvio remained consistent with previous findings through three years of treatment, with no new safety signals identified compared to previous long-term extension study interim analyses2,5

Pediatric data support nemolizumab’s potential across patient populations4

Galderma will also present clinical results from a phase II study designed to assess the pharmacokinetics, safety, and efficacy of nemolizumab in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis.4 Results showed that nemolizumab pediatric doses were associated with similar pharmacokinetic exposure compared to adults and adolescents, and were well tolerated and effective in children, with clinically meaningful reductions in skin lesions and itch through Week 16 and sustained up to Week 52.4

Long-term data reinforce sustained improvements in prurigo nodularis burden3

A separate descriptive analysis from the OLYMPIA LTE study showed that Nemluvio also delivered sustained and clinically meaningful improvements across multiple dimensions of prurigo nodularis burden through Week 148, including itch, pain, sleep disturbance, quality of life and overall health status.3 At Week 48, out of 508 enrolled patients:

More than 85% of patients achieved clinically meaningful itch improvement, with about three-quarters of patients achieving an itch-free or nearly itch-free state3

60% reported no prurigo nodularis-associated pain3

85% achieved clinically meaningful improvements in sleep disturbance3

91% experienced clinically meaningful improvements in quality of life3

The safety profile of Nemluvio remained consistent with previous findings through three years of treatment, with no new safety signals identified compared to previous long-term extension study interim analyses3

These findings reinforce that long-term treatment with Nemluvio may support not only symptom relief, but also meaningful improvements in patients' daily functioning and wellbeing.

Also at the Fall Clinical 2026 congress, Dr. Raj Chovatiya and Dr. Shawn Kwatra will present to healthcare professionals attending the congress at a Galderma-sponsored product theatre titled “Targeting the IL-31 Neuroimmune Pathway: A Case-Based Approach.” Taking place on Friday, October 9, from 12:30-1:00 PM in the Castillon room, the session will explore the role of neuroimmune interactions in prurigo nodularis and atopic dermatitis, discussing real-world cases and the potential impact of targeting the IL-31 pathway on patient outcomes.

Media can find more information and resources on atopic dermatitis and prurigo nodularis in this toolkit.

About nemolizumab

Nemolizumab is the first approved monoclonal antibody that specifically targets and inhibits the signaling of IL-31 – a neuroimmune cytokine that drives itch and is involved in inflammation, epidermal dysregulation and fibrosis in both atopic dermatitis and prurigo nodularis.6-9

Nemolizumab was initially developed by Chugai Pharmaceutical Co., Ltd. In 2016, Galderma obtained exclusive rights to the development and marketing of nemolizumab worldwide, except in Japan. In Japan, nemolizumab is marketed as Mitchga® and is approved for the treatment of prurigo nodularis in adults and children aged 13 years and older, as well as pruritus associated with atopic dermatitis in adults and children between the ages of 6 and 12.10,11

Nemolizumab (under the name Nemluvio®) was approved by the United States Food and Drug Administration for the treatment of adults with prurigo nodularis, and patients 12 years and older with moderate-to-severe atopic dermatitis, in combination with topical corticosteroids and/or calcineurin inhibitors when the disease is not adequately controlled with topical prescription therapies.7 To date, nemolizumab is approved for both adolescents and adults with moderate-to-severe atopic dermatitis and adults with prurigo nodularis in more than 40 countries around the world. Additional regulatory submissions and reviews are ongoing.

Nemluvio Important Safety Information

INDICATIONS: NEMLUVIO® (nemolizumab-ilto) is an interleukin-31 receptor alpha antagonist indicated for:

the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe atopic dermatitis in combination with topical corticosteroids and/or calcineurin inhibitors when the disease is not adequately controlled with topical prescription therapies.

the treatment of adults with prurigo nodularis.

CONTRAINDICATION: NEMLUVIO is contraindicated in patients with known hypersensitivity to nemolizumab-ilto or to any of the excipients in NEMLUVIO.

WARNINGS AND PRECAUTIONS: Hypersensitivity reactions have been reported with NEMLUVIO use. If clinically significant hypersensitivity reaction occurs, immediately institute appropriate therapy, and discontinue NEMLUVIO. Avoid use of live vaccines during treatment with NEMLUVIO.

ADVERSE REACTIONS: Most common adverse reactions (incidence ≥1%) are:

Atopic Dermatitis: headache (including migraine), arthralgia, urticaria, and myalgia.

Prurigo Nodularis: headache, dermatitis atopic, eczema, and eczema nummular.

USE IN SPECIFIC POPULATIONS:

Pregnancy: There are no adequate and well-controlled studies on NEMLUVIO in pregnant women. The limited available information on NEMLUVIO use during pregnancy is not sufficient to inform a drug-associated risk of major birth defects or miscarriage in humans. Human IgG antibodies are known to cross the placental barrier; therefore, NEMLUVIO may be transmitted from the mother to the developing fetus.

Lactation: There are no data on the presence or transfer of NEMLUVIO in human milk, the effects on the breastfed infant, or the effects on milk production. Human IgG is known to be present in human milk. The effects of local gastrointestinal and limited systemic exposure to NEMLUVIO on the breastfed infant are unknown. NEMLUVIO has not been administered to nursing/lactating women. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for NEMLUVIO and any potential adverse effects on the breastfed child from NEMLUVIO or from the underlying maternal condition.

Pediatric Use: The safety and effectiveness of NEMLUVIO have not been established in pediatric patients younger than 12 years of age for the treatment of moderate-to-severe atopic dermatitis or pediatric patients younger than 18 years of age for the treatment of prurigo nodularis.

Please see full Prescribing Information including Patient Information.

About Galderma

Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.

References

1. Elmariah, et al. Nemolizumab treatment is associated with deep and lasting skin lesion and itch responses: Results from the ARCADIA long-term-extension (LTE) study up to week 152. Presented at Fall Clinical Dermatology Conference 2026; October 8-11, 2026; Las Vegas.

2. Silverberg, et al. Long-term safety and efficacy (up to 152 weeks) of nemolizumab in ARCADIA open-label long-term extension study in adults and adolescents with moderate-to-severe atopic dermatitis. Presented at Fall Clinical Dermatology Conference 2026; October 8-11, 2026; Las Vegas.

3. Stander, et al. Evolution of clinical response with long-term nemolizumab therapy in prurigo nodularis: From symptom relief to improvements in sleep and quality of life (AS-4212). Presented at Fall Clinical Dermatology Conference 2026; October 8-11, 2026; Las Vegas.

4. Eichenfield, et al. Pharmacokinetics, safety, and efficacy of nemolizumab in children (aged 2-11 years) with moderate-to-severe atopic dermatitis. Presented at AAD 2026; March 27-31, 2026.

5. Silverberg, et al. Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 & 2): results from two replicate double-blinded, randomised controlled phase 3 trials. Lancet. 2024;404(10451):445-460. doi:10.1016/S0140-6736(24)01203-0.

6. Silverberg JI, et al. Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus. J Allergy Clin Immunol. 2020;145(1):173-182. doi: 10.1016/j.jaci.2019.08.013

7. Nemluvio U.S. Prescribing Information. Available online. Accessed March 2025

8. Nemluvio European Medicines Agency. Summary of Product Characteristics. Available online. Accessed March 2025

9. Bewley A, et al. Prurigo Nodularis: A Review of IL-31RA Blockade and Other Potential Treatments. Dermatol Ther (Heidelb). 2022;12(9):2039–2048. doi: 10.1007/s13555- 022-00782-2

10. Chugai Pharmaceutical Co., Ltd. Maruho Obtained Regulatory Approval for Mitchga, the First Antibody Targeting IL-31 for Itching Associated with Atopic Dermatitis. Available online. Accessed March 2025.

11. Chugai Pharmaceutical Co., Ltd. Mitchga Approved for Itching in Pediatric Atopic Dermatitis and Prurigo Nodularis, for its Subcutaneous Injection 30mg Vials. Available online. Accessed March 2025.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261007414473/en/

Permalink

https://www.aetoswire.com/en/news/54617802

Contacts

For further information:

Christian Marcoux, M.Sc.

Chief Communications Officer

christian.marcoux@galderma.com

+41 76 315 26 50

Richard Harbinson

Corporate Communications Director

richard.harbinson@galderma.com

+41 76 210 60 62

Céline Buguet

Franchises and R&D Communications Director

celine.buguet@galderma.com

+41 76 249 90 87

Emil Ivanov

Head of Strategy, Investor Relations, and ESG

emil.ivanov@galderma.com

+41 21 642 78 12

Jessica Cohen

Investor Relations and Strategy Director

jessica.cohen@galderma.com

+41 21 642 76 43

Dubai launches global Create AI Agents Championship with prize pool exceeding AED 2.5 million

 Dubai has launched the Create AI Agents Championship, a global competition inviting innovators to develop practical and scalable AI-agent solutions that address real-world challenges, with a total prize pool exceeding AED 2.5 million.

 

The launch of the championship was announced by H.H. Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai, Deputy Prime Minister and Minister of Defence of the UAE, and Chairman of The Executive Council of Dubai, who encouraged innovators from around the world to participate.

 

Led by Dubai Chamber of Digital Economy, the championship aims to accelerate the adoption of Agentic AI and support the development of innovative AI-agent solutions with strong potential for practical application, scalability, and commercial growth. It also seeks to encourage the creation of solutions that can deliver measurable value for individuals, businesses, and society.

 

The competition is open to innovators from technical and non-technical backgrounds, with no minimum age requirement. Individuals and teams may enter with an innovative idea, prototype, or early-stage minimum viable product, while existing businesses may submit a new AI-agent solution or capability.

 

Participants will compete across four categories: Best Societal AI Agent, Best Personal AI Agent, Best Business AI Agent, and Best Youth AI Agent. Each category winner will receive AED 550,000, while one of the four winners will also receive the AI Agent of the Year title and AED 1 million.

 

Participants are encouraged to identify priority challenges, design AI agents to address them, test their impact, and explore their potential to develop into viable and scalable products, services, and commercial ventures.

 

The championship will also provide participants with access to advanced training, practical workshops, self-paced learning content, specialised sessions, and mentorship to support the development and refinement of their solutions.

 

Registration opened on 7 October and will close in December 2026.

 

To find out more, please visit http://www.dubaichamberdigital.com/en/create-ai-agents

 

About Dubai Chamber of Digital Economy

Dubai Chamber of Digital Economy works to position Dubai as a global leader in the digital economy. Its mandate includes attracting companies, talent, and investment while creating a supportive environment for digital business growth.

Permalink

https://www.aetoswire.com/en/news/8102026579311

Contacts

Mohamad Mouzehem

mohamad.mouzehem@dubaichamber.com

Best's Market Segment Report: Sub-Saharan Africa’s Reinsurers Maintain Robust Performance Amid Moderating Market Conditions

 (BUSINESS WIRE)--Reinsurers in sub-Saharan Africa have reported another year of robust underwriting results, maintaining rate adequacy amid moderating market conditions according to a new AM Best report.

In its Best’s Market Segment Report, "Sub-Saharan Africa’s Reinsurers Maintain Robust Performance Amid Moderating Market Conditions", AM Best states that it still believes that the SSA reinsurance segment has substantial potential for continued and profitable growth and is expected to benefit from the region's considerable untapped reserves of natural resources, solid long-term economic growth prospects and increasing insurance penetration.

However, this positive trajectory is being clouded by another spell of global geopolitical uncertainty, specifically the ongoing conflict in the Middle East. The extent to which reinsurers will feel this impact will vary depending on their geographical mix of business, with diversification being a key mitigating factor.

Naz Botea, senior financial analyst at AM Best and one of the report's authors, said, "Overall, AM Best-rated reinsurers in the region are expected to remain resilient amid this dynamic risk landscape, supported by good capital buffers that have grown in recent years through robust internal capital generation, as well as the growing geographical diversification of invested assets and revenue."

This report forms part of AM Best's look at the global reinsurance industry and includes AM Best’s ranking of top global reinsurance groups and in-depth looks at the insurance-linked securities, Lloyd’s, life/annuity, health and regional reinsurance markets. These can be found at AM Best’s Reinsurance Information centre.

To access a complimentary copy of this report, please visit http://www3.ambest.com/bestweek/purchase.asp?record_code=369323.

AM Best is a global credit rating agency, news publisher and data analytics provider specialising in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2026 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260922859287/en/

Permalink

https://aetoswire.com/en/news/54609064

Contacts

Naz Botea

Senior Financial Analyst

+44 20 7397 0313

naz.botea@ambest.com

Dale Kirby

Senior Financial Analyst

+44 20 7397 0276

dale.kirby@ambest.com

Edem Kuenyehia

Director, Market Development & Communications

+44 20 7397 0280

edem.kuenyehia@ambest.com

Christopher Sharkey

Associate Director, Public Relations

+1 908 882 2310

christopher.sharkey@ambest.com